Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
55.06
-5.54 (-9.14%)
At close: Nov 13, 2024, 4:00 PM
55.73
+0.67 (1.22%)
After-hours: Nov 13, 2024, 7:53 PM EST
Viking Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 50.35 | 55.52 | 36.63 | 26.37 | 29.12 | 8.38 | Upgrade
|
| Short-Term Investments | 880.09 | 306.56 | 118.85 | 175.73 | 219.27 | 267.26 | Upgrade
|
| Cash & Short-Term Investments | 930.44 | 362.08 | 155.49 | 202.1 | 248.39 | 275.64 | Upgrade
|
| Cash Growth | 147.30% | 132.87% | -23.07% | -18.63% | -9.89% | -8.58% | Upgrade
|
| Prepaid Expenses | 1.73 | 2.52 | 3.41 | 0.62 | 0.44 | 0.41 | Upgrade
|
| Other Current Assets | 4.48 | 2.62 | 8.14 | 7.81 | 7.28 | 7.46 | Upgrade
|
| Total Current Assets | 936.65 | 367.23 | 167.04 | 210.53 | 256.1 | 283.5 | Upgrade
|
| Property, Plant & Equipment | 1.11 | 1.13 | 1.42 | 0.03 | 0.32 | 0.6 | Upgrade
|
| Long-Term Deferred Charges | 0.08 | 0.11 | 0.04 | 0.08 | 0.05 | 0.13 | Upgrade
|
| Other Long-Term Assets | 0.05 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
| Total Assets | 937.89 | 368.49 | 168.53 | 210.66 | 256.5 | 284.26 | Upgrade
|
| Accounts Payable | 0.25 | 7.51 | 8.53 | 1.44 | 3.99 | 2.43 | Upgrade
|
| Accrued Expenses | 24.95 | 11.3 | 13.11 | 7.31 | 7.81 | 4.04 | Upgrade
|
| Current Portion of Leases | 0.48 | 0.32 | 0.3 | 0.03 | 0.33 | 0.3 | Upgrade
|
| Total Current Liabilities | 25.69 | 19.14 | 21.95 | 8.78 | 12.13 | 6.78 | Upgrade
|
| Long-Term Leases | 0.76 | 0.94 | 1.26 | - | 0.03 | 0.36 | Upgrade
|
| Total Liabilities | 26.44 | 20.07 | 23.21 | 8.78 | 12.16 | 7.14 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 1,362 | 733.55 | 445.27 | 425.61 | 412.59 | 405.8 | Upgrade
|
| Retained Earnings | -452.49 | -377.94 | -292.05 | -223.18 | -168.19 | -128.7 | Upgrade
|
| Treasury Stock | - | -6.8 | -6.8 | - | - | - | Upgrade
|
| Comprehensive Income & Other | 1.63 | -0.39 | -1.1 | -0.55 | -0.05 | 0.01 | Upgrade
|
| Shareholders' Equity | 911.45 | 348.42 | 145.32 | 201.88 | 244.34 | 277.12 | Upgrade
|
| Total Liabilities & Equity | 937.89 | 368.49 | 168.53 | 210.66 | 256.5 | 284.26 | Upgrade
|
| Total Debt | 1.24 | 1.26 | 1.56 | 0.03 | 0.36 | 0.66 | Upgrade
|
| Net Cash (Debt) | 929.21 | 360.82 | 153.92 | 202.07 | 248.03 | 274.98 | Upgrade
|
| Net Cash Growth | 147.85% | 134.42% | -23.83% | -18.53% | -9.80% | -8.80% | Upgrade
|
| Net Cash Per Share | 8.75 | 3.82 | 2.00 | 2.62 | 3.42 | 3.82 | Upgrade
|
| Filing Date Shares Outstanding | 111.44 | 100.49 | 78.42 | 78.36 | 74.13 | 72.56 | Upgrade
|
| Total Common Shares Outstanding | 111.43 | 100.11 | 78.26 | 78.25 | 73.22 | 72.41 | Upgrade
|
| Working Capital | 910.96 | 348.09 | 145.09 | 201.75 | 243.98 | 276.72 | Upgrade
|
| Book Value Per Share | 8.18 | 3.48 | 1.86 | 2.58 | 3.34 | 3.83 | Upgrade
|
| Tangible Book Value | 911.45 | 348.42 | 145.32 | 201.88 | 244.34 | 277.12 | Upgrade
|
| Tangible Book Value Per Share | 8.18 | 3.48 | 1.86 | 2.58 | 3.34 | 3.83 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.